Cassava Sciences (SAVA) Short Interest Ratio & Short Volume $2.28 +0.01 (+0.62%) As of 09:43 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cassava Sciences Short Interest DataCassava Sciences (SAVA) has a short interest of 6.24 million shares. This marks a -1.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.9, indicating that it would take 6.9 days of the average trading volume of 1.37 million shares to cover all short positions.Current Short Interest6,240,000 sharesPrevious Short Interest6,320,000 sharesChange Vs. Previous Month-1.27%Dollar Volume Sold Short$14.60 millionShort Interest Ratio6.9 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares48,310,000 sharesPercentage of Shares Shorted12.92%Today's Trading Volume5,556 sharesAverage Trading Volume1,374,581 sharesToday's Volume Vs. Average0% Short Selling Cassava Sciences? Sign up to receive the latest short interest report for Cassava Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSAVA Short Interest Over TimeSAVA Days to Cover Over TimeSAVA Percentage of Float Shorted Over Time Cassava Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20256,240,000 shares $14.60 million -1.3%N/A6.9 $2.34 7/31/20256,320,000 shares $13.27 million +0.6%13.4%5.9 $2.10 7/15/20256,280,000 shares $12.94 million -10.3%N/A5.9 $2.06 6/30/20257,000,000 shares $12.67 million -14.8%14.8%6.5 $1.81 6/15/20258,220,000 shares $16.85 million -6.9%17.4%6 $2.05 5/31/20258,830,000 shares $17.92 million -12.0%20.2%6.2 $2.03 5/15/202510,030,000 shares $20.56 million No Change22.9%6.3 $2.05 4/30/202510,030,000 shares $15.65 million -9.6%N/A6.5 $1.56 4/15/202511,090,000 shares $15.86 million -0.5%25.3%6.8 $1.43 3/31/202511,150,000 shares $16.73 million -6.1%25.5%5.9 $1.50 Get the Latest News and Ratings for SAVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cassava Sciences and its competitors with MarketBeat's FREE daily newsletter. 3/15/202511,880,000 shares $33.15 million -17.8%27.1%5.2 $2.79 2/28/202514,450,000 shares $34.68 million -9.4%33.0%5.6 $2.40 2/15/202515,940,000 shares $38.57 million +0.6%36.4%3 $2.42 1/31/202515,850,000 shares $37.72 million +3.2%N/A2.9 $2.38 1/15/202515,360,000 shares $41.63 million -7.6%N/A2.8 $2.71 12/31/202416,630,000 shares $39.25 million -5.6%N/A3 $2.36 12/15/202417,620,000 shares $48.46 million +2.7%N/A3.4 $2.75 11/30/202417,160,000 shares $65.89 million -5.1%N/A3.5 $3.84 11/15/202418,080,000 shares $486.53 million -2.6%N/A4.9 $26.91 10/31/202418,570,000 shares $479.20 million -2.0%N/A10.7 $25.81 10/15/202418,940,000 shares $535.24 million +7.4%N/A7.2 $28.26 9/30/202417,630,000 shares $518.85 million +10.8%N/A5.6 $29.43 9/15/202415,910,000 shares $447.39 million +0.6%N/A4.6 $28.12 8/31/202415,810,000 shares $453.91 million -10.6%N/A4.9 $28.71 8/15/202417,680,000 shares $501.94 million -7.1%N/A5.6 $28.39 7/31/202419,030,000 shares $422.85 million +18.0%N/A6.5 $22.22 7/15/202416,130,000 shares $198.88 million +23.2%N/A8.3 $12.33 6/30/202413,090,000 shares $161.66 million +3.5%N/A9 $12.35 6/15/202412,650,000 shares $249.46 million +1.7%N/A15.7 $19.72 5/31/202412,440,000 shares $274.05 million -2.8%N/A15 $22.03 5/15/202412,800,000 shares $294.53 million -7.7%N/A15.4 $23.01 4/30/202413,870,000 shares $307.22 million +8.0%N/A17.4 $22.15 4/15/202412,840,000 shares $256.93 million +8.9%N/A17.7 $20.01 3/31/202411,790,000 shares $239.22 million -1.4%N/A17 $20.29 3/15/202411,960,000 shares $254.63 million +5.7%30.5%15.7 $21.29 2/29/202411,320,000 shares $260.13 million -3.7%28.9%11.4 $22.98 2/15/202411,760,000 shares $288.94 million -3.5%30.7%12.3 $24.57 1/31/202412,180,000 shares $291.71 million -8.6%31.8%11.5 $23.95 1/15/202413,330,000 shares $349.78 million -4.0%33.6%10.2 $26.24 12/31/202313,890,000 shares $312.66 million +8.9%35.0%9.2 $22.51This Coin Could Explode, and it’s Hiding in Plain Sight! (Ad)The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain sight...Click here to discover The #1 Coin To Own Right Now. 12/15/202312,760,000 shares $268.96 million -7.0%32.2%8.6 $21.08 11/30/202313,720,000 shares $285.79 million -5.8%34.7%11.2 $20.83 11/15/202314,560,000 shares $317.70 million -8.9%36.8%11.3 $21.82 10/31/202315,990,000 shares $322.20 million +14.1%40.6%12.4 $20.15 10/15/202314,020,000 shares $208.34 million -1.3%35.6%13.1 $14.86 9/30/202314,210,000 shares $236.45 million +3.7%36.1%17.2 $16.64 9/15/202313,700,000 shares $265.92 million +2.7%34.8%14.8 $19.41 8/31/202313,340,000 shares $279.74 million +8.8%33.9%14.8 $20.97 8/15/202312,260,000 shares $215.16 million +7.3%31.1%14.9 $17.55 7/31/202311,430,000 shares $251.23 million +2.1%29.0%13.4 $21.98 7/15/202311,200,000 shares $242.26 million +10.5%28.6%13.9 $21.63 6/30/202310,140,000 shares $248.63 million +8.1%25.9%13 $24.52 6/15/20239,380,000 shares $235.16 million -13.2%23.9%14.4 $25.07 5/31/202310,800,000 shares $245.27 million +6.3%27.6%15.2 $22.71 5/15/202310,160,000 shares $269.34 million -7.5%25.9%14.4 $26.51 4/30/202310,980,000 shares $254.96 million -0.6%28.0%14.5 $23.22 4/15/202311,050,000 shares $257.69 million -3.9%28.2%10.1 $23.32 3/31/202311,500,000 shares $277.38 million +9.9%30.0%9.7 $24.12 3/15/202310,460,000 shares $272.48 million -5.0%27.3%7.9 $26.05 2/28/202311,010,000 shares $271.95 million +3.9%28.7%7.9 $24.70 2/15/202310,600,000 shares $279.95 million +7.6%27.6%7.6 $26.41 1/31/20239,850,000 shares $275.80 million -4.6%25.1%6.4 $28.00 1/15/202310,320,000 shares $350.88 million +18.8%26.3%7.3 $34.00 12/30/20228,690,000 shares $256.70 million -1.3%22.1%7 $29.54 12/15/20228,800,000 shares $348.22 million -5.7%22.4%5.6 $39.57 11/30/20229,330,000 shares $324.96 million No Change23.8%4 $34.83 11/15/20229,330,000 shares $374.13 million -0.4%23.8%3.7 $40.10 10/31/20229,370,000 shares $341.44 million -2.7%24.9%2.8 $36.44 10/15/20229,630,000 shares $351.11 million -10.7%25.6%2.6 $36.46 9/30/202210,780,000 shares $450.82 million -14.1%N/A2.9 $41.82 9/15/202212,550,000 shares $396.33 million -0.2%N/A3.7 $31.58 8/31/202212,580,000 shares $323.68 million +4.4%N/A5.1 $25.73 8/15/202212,050,000 shares $243.29 million +5.4%N/A5.1 $20.19 7/31/202211,430,000 shares $186.65 million +12.3%N/A7.7 $16.33 7/15/202210,180,000 shares $243.40 million -2.2%N/A8.4 $23.91 6/30/202210,410,000 shares $292.73 million -5.1%N/A7.1 $28.12 6/15/202210,970,000 shares $294.00 million -4.9%N/A6.7 $26.80 5/31/202211,530,000 shares $352.82 million -2.7%30.9%7 $30.60 5/15/202211,850,000 shares $227.99 million +0.9%31.8%7.5 $19.24 4/30/202211,750,000 shares $245.22 million +2.5%31.5%6.9 $20.87 4/15/202211,460,000 shares $300.83 million +7.4%31.5%6.5 $26.25 3/31/202210,670,000 shares $396.28 million -2.4%29.4%6.4 $37.14 3/15/202210,930,000 shares $380.91 million -3.3%30.1%5.1 $34.85 2/28/202211,300,000 shares $480.36 million -5.4%31.1%4.7 $42.51 2/15/202211,950,000 shares $588.18 million -12.1%32.9%4.7 $49.22 1/31/202213,600,000 shares $601.80 million +4.7%37.4%4.4 $44.25 1/15/202212,990,000 shares $595.98 million -4.6%34.8%2.8 $45.88 12/31/202113,610,000 shares $594.76 million +11.7%36.5%2.8 $43.70 12/15/202112,190,000 shares $558.06 million +18.9%N/A2.2 $45.78 11/30/202110,250,000 shares $548.27 million +22.3%27.5%1.7 $53.49Why Trump’s “Smart Dollar” could rewrite the rules (Ad)MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.Get the three steps to take this month to put yourself on the right side of this $30 trillion money 11/15/20218,380,000 shares $507.07 million -26.2%22.5%1 $60.51 10/29/202111,350,000 shares $489.53 million +20.5%30.4%1.3 $43.13 10/15/20219,420,000 shares $468.08 million +7.4%25.3%1.2 $49.69 9/30/20218,770,000 shares $544.44 million -1.2%23.5%1.1 $62.08 9/15/20218,880,000 shares $390.01 million +12.4%23.8%1.1 $43.92 8/31/20217,900,000 shares $449.12 million +46.3%21.2%1.1 $56.85 8/13/20215,400,000 shares $661.88 million +35.0%14.5%1.3 $122.57 7/30/20214,000,000 shares $278.12 million -9.5%10.7%1 $69.53 7/15/20214,420,000 shares $364.34 million +11.6%11.9%1.7 $82.43 6/30/20213,960,000 shares $338.34 million +5.3%10.6%1.8 $85.44 6/15/20213,760,000 shares $271.10 million -0.5%10.1%2 $72.10 5/28/20213,780,000 shares $203.82 million +8.9%10.1%2.1 $53.92 5/14/20213,470,000 shares $131.10 million -7.7%N/A1.9 $37.78 4/30/20213,760,000 shares $178.86 million +3.6%N/A1.2 $47.57 4/15/20213,630,000 shares $129.48 million +5.5%N/A0.6 $35.67 3/31/20213,440,000 shares $151.22 million -5.8%N/A0.5 $43.96 3/15/20213,650,000 shares $195.06 million +24.2%N/A0.5 $53.44 2/26/20212,940,000 shares $149.59 million +12.2%N/A0.4 $50.88 2/12/20212,620,000 shares $126.26 million -56.2%N/A0.4 $48.19 1/29/20215,980,000 shares $111.95 million +9.5%N/A1 $18.72 1/15/20215,460,000 shares $57.22 million +2.1%N/A1.6 $10.48 12/31/20205,350,000 shares $37.50 million +2.9%N/A2 $7.01 12/15/20205,200,000 shares $40.35 million -12.9%N/A1.7 $7.76 11/30/20205,970,000 shares $46.33 million -0.3%N/A0.7 $7.76 11/15/20205,990,000 shares $50.14 million +11.8%N/A0.7 $8.37 10/30/20205,360,000 shares $46.79 million +15.5%N/A0.7 $8.73 10/15/20204,640,000 shares $50.99 million -6.8%N/A0.7 $10.99 9/30/20204,980,000 shares $57.32 million +79.1%N/A0.7 $11.51 9/15/20202,780,000 shares $19.52 million -8.0%N/A0.4 $7.02 SAVA Short Interest - Frequently Asked Questions What is Cassava Sciences' current short interest? Short interest is the volume of Cassava Sciences shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 6,240,000 shares of SAVA short. Learn More on Cassava Sciences' current short interest. What is a good short interest ratio for Cassava Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SAVA shares currently have a short interest ratio of 7.0. Learn More on Cassava Sciences's short interest ratio. Which institutional investors are shorting Cassava Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cassava Sciences: Group One Trading LLC, Jane Street Group LLC, Diadema Partners LP, Walleye Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cassava Sciences' short interest increasing or decreasing? Cassava Sciences saw a drop in short interest during the month of August. As of August 15th, there was short interest totaling 6,240,000 shares, a drop of 1.3% from the previous total of 6,320,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cassava Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cassava Sciences: Corvus Pharmaceuticals, Inc. (12.47%), Kamada Ltd. (0.22%), Aura Biosciences, Inc. (6.59%), I-Mab Sponsored ADR (2.69%), Y-mAbs Therapeutics, Inc. (4.81%), Aquestive Therapeutics, Inc. (8.43%), Vigil Neuroscience, Inc. (1.40%), Olema Pharmaceuticals, Inc. (12.36%), Rocket Pharmaceuticals, Inc. (10.87%), Inhibrx Biosciences, Inc. (7.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short Cassava Sciences stock? Short selling SAVA is an investing strategy that aims to generate trading profit from Cassava Sciences as its price is falling. SAVA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cassava Sciences? A short squeeze for Cassava Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SAVA, which in turn drives the price of the stock up even further. How often is Cassava Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SAVA, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies Corvus Pharmaceuticals Short Interest Data Kamada Short Interest Data Aura Biosciences Short Interest Data I-Mab Short Interest Data Y-mAbs Therapeutics Short Interest Data Aquestive Therapeutics Short Interest Data Vigil Neuroscience Short Interest Data Olema Pharmaceuticals Short Interest Data Rocket Pharmaceuticals Short Interest Data Inhibrx Biosciences Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SAVA) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cassava Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SAVA Stock Alerts